Literature DB >> 16336018

A willingness-to-pay assessment of parents' preference for shorter duration treatment of acute otitis media in children.

Delphine Gueylard Chenevier1, Jacques LeLorier.   

Abstract

OBJECTIVE: To assess parental willingness to pay (WTP) for a shorter course of antibacterial treatment versus conventional antibacterial therapy for acute otitis media (AOM).
METHODS: The study population consisted of 562 parents of children who had been seen and treated by a paediatrician for an episode of AOM between February and November 2002 in Montreal, Quebec, Canada. At the end of the AOM treatment, a questionnaire that included demographic information about the parents and child, details of the child's AOM history, a global wellbeing (i.e. quality of life) assessment, an evaluation of treatment compliance and a scripted WTP question was administered over the telephone. Descriptive analyses were performed in addition to a multivariate analysis to estimate possible predictors of parental WTP.
RESULTS: The children with AOM were representative of the AOM patient population, with 46% being <2 years of age and the majority attending day-care or school. Parents were willing to pay a median of 31.66 Can dollars (2002 values) for a mono-dose (one dose, on 1 day) and 26.63 Can dollars for a tri-dose (one dose daily, for 3 days) antibacterial treatment. Regression analyses demonstrated that the amount parents were willing to pay was positively associated with increasing household income, increasing number of AOM episodes during the previous year and experiencing adverse effects of treatment.
CONCLUSION: Parents of children with AOM were willing to pay more for their child to benefit from a shorter duration of antibacterial treatment than for a standard course. Short duration of treatment appears to be associated with better compliance and parents' perception of better general wellbeing for their child.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16336018     DOI: 10.2165/00019053-200523120-00008

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  29 in total

Review 1.  Theory versus practice: a review of 'willingness-to-pay' in health and health care.

Authors:  J A Olsen; R D Smith
Journal:  Health Econ       Date:  2001-01       Impact factor: 3.046

2.  Willingness-to-pay as a measure of benefits. Relevant questions in the context of public decisionmaking about health care programs.

Authors:  A Gafni
Journal:  Med Care       Date:  1991-12       Impact factor: 2.983

3.  Evidence assessment of management of acute otitis media: I. The role of antibiotics in treatment of uncomplicated acute otitis media.

Authors:  G S Takata; L S Chan; P Shekelle; S C Morton; W Mason; S M Marcy
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

4.  Compliance of German pediatric patients with oral antibiotic therapy: results of a nationwide survey.

Authors:  J E Hoppe; G Blumenstock; W Grotz; H K Selbmann
Journal:  Pediatr Infect Dis J       Date:  1999-12       Impact factor: 2.129

5.  Economic value to parents of reducing the pain and emotional distress of childhood vaccine injections.

Authors:  A S Meyerhoff; B G Weniger; R J Jacobs
Journal:  Pediatr Infect Dis J       Date:  2001-11       Impact factor: 2.129

6.  Six-day amoxicillin vs. ten-day penicillin V therapy for group A streptococcal tonsillopharyngitis.

Authors:  R Cohen; C Levy; C Doit; F De La Rocque; M Boucherat; F Fitoussi; J Langue; E Bingen
Journal:  Pediatr Infect Dis J       Date:  1996-08       Impact factor: 2.129

Review 7.  Otitis media: focus on antimicrobial resistance and new treatment options.

Authors:  H L Hoppe; C E Johnson
Journal:  Am J Health Syst Pharm       Date:  1998-09-15       Impact factor: 2.637

Review 8.  Otitis media.

Authors:  Maroeska M Rovers; Anne G M Schilder; Gerhard A Zielhuis; Richard M Rosenfeld
Journal:  Lancet       Date:  2004-02-07       Impact factor: 79.321

9.  Measuring patient preferences by willingness to pay to avoid: the case of acute otitis media.

Authors:  P C Sorum
Journal:  Med Decis Making       Date:  1999 Jan-Mar       Impact factor: 2.583

Review 10.  Natural history of untreated otitis media.

Authors:  Richard M Rosenfeld; David Kay
Journal:  Laryngoscope       Date:  2003-10       Impact factor: 3.325

View more
  7 in total

1.  Validations of the OM-6 Parent-Proxy Survey for Infants/Toddlers with Otitis Media.

Authors:  Joy Tao; Kristine Schulz; Donna B Jeffe; Judith E C Lieu
Journal:  Otolaryngol Head Neck Surg       Date:  2018-01-09       Impact factor: 3.497

Review 2.  Understanding Patient Preferences in Medication Nonadherence: A Review of Stated Preference Data.

Authors:  Tracey-Lea Laba; Beverley Essue; Merel Kimman; Stephen Jan
Journal:  Patient       Date:  2015-10       Impact factor: 3.883

3.  Are adult patients more tolerant of treatment risks than parents of juvenile patients?

Authors:  F Reed Johnson; Semra Ozdemir; Carol Mansfield; Steven Hass; Corey A Siegel; Bruce E Sands
Journal:  Risk Anal       Date:  2008-09-26       Impact factor: 4.000

4.  Caregiver Quality of Life Is Related to Severity of Otitis Media in Children.

Authors:  Sarah J Blank; David J Grindler; Kristine A Schulz; David L Witsell; Judith E C Lieu
Journal:  Otolaryngol Head Neck Surg       Date:  2014-04-18       Impact factor: 3.497

5.  Impact of Otitis Media Severity on Children's Quality of Life.

Authors:  David J Grindler; Sarah J Blank; Kristine A Schulz; David L Witsell; Judith E C Lieu
Journal:  Otolaryngol Head Neck Surg       Date:  2014-03-13       Impact factor: 3.497

6.  Willingness-to-pay to avoid the time spent and discomfort associated with screening colonoscopy.

Authors:  Daniel E Jonas; Louise B Russell; Jon Chou; Michael Pignone
Journal:  Health Econ       Date:  2010-10       Impact factor: 3.046

7.  A 3-day regimen with azithromycin 1.5% eyedrops for the treatment of purulent bacterial conjunctivitis in children: efficacy on clinical signs and impact on the burden of illness.

Authors:  Dominique Bremond-Gignac; Riadh Messaoud; Sihem Lazreg; Claude Speeg-Schatz; Didier Renault; Frédéric Chiambaretta
Journal:  Clin Ophthalmol       Date:  2015-04-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.